INVITATION
Dear Colleagues,
It is our great pleasure to announce that the Turkish Association for Psychopharmacology (TAP)'s 13th International Congress on Psychopharmacology & International Symposium on Child and Adolescent Psychopharmacology (ICP 2022) will be held on November 09-12, 2022 in Antalya, Turkey.
After a hybrid edition, we are happy to invite you to join us again in an entire face-to-face meeting and make the ICP 2022 a memorable event. The motto of the congress is Overcoming Challenges: Psychiatry and Psychopharmacology in the Post-pandemic era. During this four-day congress; distinguished national and international speakers and researchers will provide up-to-date information and the latest outstanding breakthroughs in psychopharmacology as well as other fields of clinical practice along with interactively sharing the latest trends in treatment-resistant cases and will offer practical solutions to contemporary challenges clinicians face and also review the latest developments in basic sciences, biological psychiatry, neuroscience, and psychiatric neuroimaging. Additionally, we aim to contribute to the integrative approach in psychiatric treatments through comprehensive discussions about diagnostic approaches, psychotherapies and other non-pharmacological treatments, and their administration standards and guidelines, which are bolstered by the most up-to-date clinical research.
A major objective of the ICP 2022 will be to facilitate a closer relationship between the clinical practitioner and the researcher. Like our previous congresses, renowned speakers will share the latest developments in the field through plenary lectures, symposia, double conferences and debates. ICP 2022 also offers workshops, meet the expert sessions and courses which will be available organized for all participants. All sessions are expected to pave the way for an engagement with state-of-the-art clinical tools, to learn directly from the experts, explore innovative ideas for etiological understanding, diagnosis and treatment, and expand the frontiers of research.
As in every ICP, the best three self-nominated oral/ poster research presentation abstracts accepted for presentation and presented at the congress will be awarded the ICP 2022 Outstanding Research Presentations Awards by the Scientific Committee. In the evaluation process, Brief Reports of the ICP 2022 Outstanding Research Presentation Awards nominated studies will be assessed and published online in the Conference Proceedings, which will also include all presented abstracts and speech texts.
We are confident that ICP 2022 will represent for all participants an unforgettable personal and professional experience through benefiting from the stimulating and enriched scientific sessions and networking with inspiring researchers and clinicians from all over the world. We look forward to welcoming you to Antalya!
Kindest regards,
M. Kemal Sayar (Turkey)
President
Turkish Association of Psychopharmacology & Congress
Mucahit Ozturk (Turkey)
Co-President (Child & Adolescent Psychiatry)
It is our great pleasure to announce that the Turkish Association for Psychopharmacology (TAP)'s 13th International Congress on Psychopharmacology & International Symposium on Child and Adolescent Psychopharmacology (ICP 2022) will be held on November 09-12, 2022 in Antalya, Turkey.
After a hybrid edition, we are happy to invite you to join us again in an entire face-to-face meeting and make the ICP 2022 a memorable event. The motto of the congress is Overcoming Challenges: Psychiatry and Psychopharmacology in the Post-pandemic era. During this four-day congress; distinguished national and international speakers and researchers will provide up-to-date information and the latest outstanding breakthroughs in psychopharmacology as well as other fields of clinical practice along with interactively sharing the latest trends in treatment-resistant cases and will offer practical solutions to contemporary challenges clinicians face and also review the latest developments in basic sciences, biological psychiatry, neuroscience, and psychiatric neuroimaging. Additionally, we aim to contribute to the integrative approach in psychiatric treatments through comprehensive discussions about diagnostic approaches, psychotherapies and other non-pharmacological treatments, and their administration standards and guidelines, which are bolstered by the most up-to-date clinical research.
A major objective of the ICP 2022 will be to facilitate a closer relationship between the clinical practitioner and the researcher. Like our previous congresses, renowned speakers will share the latest developments in the field through plenary lectures, symposia, double conferences and debates. ICP 2022 also offers workshops, meet the expert sessions and courses which will be available organized for all participants. All sessions are expected to pave the way for an engagement with state-of-the-art clinical tools, to learn directly from the experts, explore innovative ideas for etiological understanding, diagnosis and treatment, and expand the frontiers of research.
As in every ICP, the best three self-nominated oral/ poster research presentation abstracts accepted for presentation and presented at the congress will be awarded the ICP 2022 Outstanding Research Presentations Awards by the Scientific Committee. In the evaluation process, Brief Reports of the ICP 2022 Outstanding Research Presentation Awards nominated studies will be assessed and published online in the Conference Proceedings, which will also include all presented abstracts and speech texts.
We are confident that ICP 2022 will represent for all participants an unforgettable personal and professional experience through benefiting from the stimulating and enriched scientific sessions and networking with inspiring researchers and clinicians from all over the world. We look forward to welcoming you to Antalya!
Kindest regards,
M. Kemal Sayar (Turkey)
President
Turkish Association of Psychopharmacology & Congress
Mucahit Ozturk (Turkey)
Co-President (Child & Adolescent Psychiatry)
